Management of acute kidney injury in gastrointestinal tumor: An overview

doi:10.12998/wjcc.v9.i35.10746

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 35

This Article

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8515)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

423

WORD

241

HTML

3265

Tables (1-1)

1019

Sum=4948

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

401

Download

1147

Sum=1548

Publishing Process of This Article

Item

Count

Browse

603

Download

1417

Sum=2020

Dec 16, 2021 (publication date) through Feb 25, 2026

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Clin Cases. Dec 16, 2021; 9(35): 10746-10764
Published online Dec 16, 2021. doi: 10.12998/wjcc.v9.i35.10746

Management of acute kidney injury in gastrointestinal tumor: An overview

Yi-Qi Su, Yi-Yi Yu, Bo Shen, Feng Yang, Yu-Xin Nie

Yi-Qi Su, Department of Nephrology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen 361015, Fujian Province, China

Yi-Yi Yu, Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Bo Shen, Yu-Xin Nie, Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai 200032, China

Feng Yang, Department of Pancreatic Surgery, Pancreatic Disease Institute, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China

Author contributions: Su YQ and Shen B designed, reviewed the manuscript; Su YQ wrote the manuscript; Yu YY, Yang F and Nie YX proofread the manuscript; all authors have read and approved the final manuscript.

Supported by Shanghai ShenKang Hospital Development Center, No. SHDC12018127.

Conflict-of-interest statement: The authors declare that they have no conflicts of interest.

Corresponding author: Yu-Xin Nie, MD, Attending Doctor, Department of Nephrology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China. nie.yuxin@zs-hospital.sh.cn

Received: March 3, 2021
Peer-review started: March 3, 2021
First decision: June 23, 2021
Revised: July 8, 2021
Accepted: September 6, 2021
Article in press: September 6, 2021
Published online: December 16, 2021
Processing time: 281 Days and 23.9 Hours

Abstract

Gastrointestinal tumors remain a global health problem. Acute kidney injury (AKI) is a common complication during the treatment of gastrointestinal tumors. AKI can cause a decrease in the remission rate and an increase in mortality. In this review, we analyzed the causes and risk factors for AKI in gastrointestinal tumor patients. The possible mechanisms of AKI were divided into three groups: pretreatment, intrafraction and post-treatment causes. Treatment and prevention measures were proposed according to various factors to provide guidance to clinicians and oncologists that can reduce the incidence of AKI and improve the quality of life and survival rate of gastrointestinal tumor patients.

Keywords: Gastrointestinal tumor; Acute kidney injury; Risk factors; Treatment; Preventive measures; Enhanced recovery pathways

Core tip: This review analyzed the causes and risk factors for acute kidney injury (AKI) in gastrointestinal tumor patients, and possible mechanism of AKI were divided into three groups: pretreatment, intrafraction and post-treatment causes. In response to these possible causes of AKI, treatment and preventive measures have been proposed based on the latest developments. This article intends to provide guidance of AKI during the treatment of gastrointestinal tumor patients to clinicians and oncologists.